The long and costly development process for the development of new pharmaceuticals places huge commercial pressures on companies to secure Marketing Authorisations in the shortest time.

Regulatory agency meetings play an important part in responding to agency concerns and developing a consensus for the development and registration process. Effective agency interactions, communication, and management are critical to the timely success of product approval.